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Context:Obesity and irondeficiency are twoof themost commonnutritional disordersworldwide.
Several studies found higher rates of iron deficiency in obese than in normal-weight children.
Hepcidin represents themain inhibitor of intestinal iron absorption, and its expression is increased
in adipose tissue of obese patients. Leptin is able, in vitro, to raise hepcidin expression.
Objectives:Aimsof thisworkwere1) toassess theassociationbetweenpoor ironstatusandobesity,
2) to investigatewhether iron homeostasis of obese childrenmay bemodulated by serumhepcidin
variations, and 3) to assess the potential correlationbetween leptin and serumhepcidin variations.
Methods: Iron status and absorption as well as hepcidin, leptin, and IL-6 levels were studied in 60
obese children and in 50 controls.
Results: Obese children showed lower iron and transferrin saturation (both P  0.05) and higher
hepcidin levels (P  0.004) compared with controls. A direct correlation between hepcidin and
obesity degree (P  0.0015), and inverse correlations between hepcidin and iron (P  0.04), hep-
cidin and transferrin saturation (P  0.005), and hepcidin and iron absorption (P  0.003) were
observed. A correlation between leptin and hepcidin (P 0.006) has been found. The correlation
remained significant when adjusted for body mass index, sex, pubertal stage, and IL-6 values.
Conclusions: We propose that in obese patients, increased hepcidin production, at least partly
leptinmediated, represents themissing linkbetweenobesityanddisrupted ironmetabolism. (JClin
Endocrinol Metab 94: 5102–5107, 2009)
Nutrition in childhood has a significant impact on life-long health. Obesity and iron deficiency are two of
the most common nutritional disorders worldwide (1).
The prevalence of overweight among children and ado-
lescents has been increasing at an alarming rate (2). Iron
deficiency during childhoodwas associatedwith impaired
cognitive function, developmental delays, and behavioral
and learning disturbances (3–5).
Several studies have consistently found higher rates of
iron deficiency in obese children and adolescents. Partic-
ularly, two epidemiological studies published in the early
1960s noted an association between overweight status
among children and adolescents and iron deficiency (6, 7).
More recently, data from theAmericanNationalHealth
and Nutrition Examination Survey III as well as data
obtained in children from transition countries (Mo-
rocco and India) have suggested that among children,
the prevalence of iron deficiency increases as body mass
index (BMI) increases from normal weight to at risk for
obesity to obesity (8–11).
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A number of different factors have been typically pro-
posed to explain the association between iron deficiency
and overweight. Eating unbalanced meals (e.g. low-cost
fast food) that are particularly rich in carbohydrates and
fat but contain a low quantity of essential nutrient such as
iron has been claimed as themost important cause for this
association (7).
Radically changing this sound point of view, a recent
study investigating the intake of heme and nonheme iron
in a convenience sample of more than 200 obese subjects
showed that differences in iron intake, or of dietary fac-
tors known to affect iron absorption, were not associ-
ated with the lower serum iron concentrations found in
obese patients (12).
Adipose tissue is now recognized as an endocrine organ
that can contribute to the inflammatory process by secret-
ing proinflammatory cytokines, also named adipokines,
and the resulted inflammatory state may have an impor-
tant pathogenic role in someobesity-related comorbidities
(13). Some studies have recently supported the idea that
iron deficiency could represent one of the comorbidities
associated with the typical chronic low-grade inflamma-
tion state of obese patients. In a cross-sectional analysis,
examining the relationshipbetween adiposity, serum iron,
serum transferrin, and measures of inflammation in a
group of obese adults, hypoferremia appeared to be ex-
plained by inflammatory-mediated functional iron defi-
ciency (14). This linkwas reinforcedby the observation that
bariatric surgery resulting in significant and long-lasting
weight loss reduces inflammation and, consequently, im-
proves iron status in morbidly obese patients (15). Further-
more, confirming the link between adiposity and iron me-
tabolism,a recent research inThaiwomenhasdemonstrated
that, independently of iron status, greater adiposity is asso-
ciated with lower fractional iron absorption (11).
The identificationof hepcidin, a 25-amino-acid peptide
produced prevalently in the liver, opened a new era in our
understanding of iron metabolism (16). Hepcidin repre-
sents the main regulator of intestinal iron absorption and
macrophage iron release and, thus, ultimately of the iron
available for erythropoiesis (17, 18). Mice in which the
hepcidin gene was inactivated develop iron overload,
whereas transgenicmice overexpressinghepcidin showse-
vere iron-deficiency anemia (17, 19). Hepcidin is also
known to be increased in humans in generalized inflam-
matory disorders, causing anemiaof chronic diseases (20).
Evidence, in fact, has been provided for a tight direct cor-
relation between hepcidin expression and some cytokines
such as IL-6 and C-reactive protein that are increased in
obesity (21). To strengthen the possible link between the
poor iron status of obesity and hepcidin, there is the in-
terestingobservation that hepcidin is expressednot only in
the liver but also in adipose tissue and that mRNA ex-
pression is increased in adipose tissue of obese patients
(22). In the human liver cell line HuH7, IL-6-mediated
hepcidin expression requires a signal transducer and ac-
tivator of transcription 3 (STAT3)-binding motif located
at position 64/72 of the promoter (23). This binding
motif is a key effector of hepcidin expression also during
inflammatory conditions (23).Using the samekindof cells
(i.e.HuH7),Chung et al. (24) have recently shown that the
adipokine leptin is able to increase hepatic hepcidin ex-
pression, sharing the same signaling pathway (i.e. Janus
kinase/STAT3) than IL-6.
The aims of this study were 1) to assess the association
between poor iron status and obesity in a group of 60
Italian obese children and adolescents and 50 matched
controls, 2) to evaluate in the same subjects the serum
hepcidin levels and to investigate whether the iron status
and absorption of these children may be modulated by
serumhepcidin variations, and3) to assess, in this context,
the possible correlation between leptin and serum hepci-
din variations.
Patients and Methods
Patients
Iron statusandabsorptionaswell ashepcidin, leptin, and IL-6
serum levels have been evaluated in a group of 60 obese children
[29 girls; mean age, 11.3  2.5 yr; mean BMI SD score (SDS),
2.70.5]whohave attended theDepartment of Pediatrics of the
Second University of Naples between January 2007 and June
2008 to take part in a weight loss program and in 50 sex- and
age-matched lean controls who consulted the Department for
presumed diseases and were found to be normal (25). Main an-
thropometric features of these two groups of subjects are re-
ported in Table 1.
Weight and height of all the subjects involved in the research
were measured, and BMI was calculated as previously shown
(26). BMI exceeding the 95th percentile was used for obesity
diagnosis. Controls had BMI below the 85th percentile. SDS for
BMI were calculated by using the Lambda-mu-sigma method
(27). Pubertal status (Table 1) was evaluated according to the
criteria of Tanner (28). Among the pubertal girls, none showed
clinical relevant menstrual irregularity, and eight obese girls and
three controls appeared to be in the follicular phase.
Blood samples for hemoglobin, iron status, hepcidin, IL-6,
and leptin evaluations were drawn in the morning (at 0800 h)
after overnight fasting. Hemoglobin was measured in whole
blood using an automated Coulter counter, and cutoff points
used to define anemia were based on the 5th percentiles for the
reference groups (29).
Procedures followed were in accordance with the Helsinki
Declaration of 1975 as revised in 1983. The ethical committee of
the Second University of Study of Naples approved the study.
Informed consent was obtained by parents and, where appro-
priate, by children.
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Iron status evaluation
Iron status has been assessed by serum iron, transferrin, and
ferritin concentrations. Transferrin saturation has been calcu-
lated. Particularly for serum iron, an iron ferrozine complex
method was used with sensitivity of 5 g/dl; serum transferrin
wasmeasuredusinga turbidimetricmethodwith sensitivityof70
mg/dl. Serum ferritin was measured by immunometric assay.
Transferrin saturation was calculated by finding the molar ratio
of serum iron and twice the serum transferrin (because each
transferrin molecule can bind two atoms of iron) using the for-
mula: transferrin saturation [serum iron (micrograms per de-
ciliter)/transferrin (milligrams per deciliter)]  71.2.
Iron absorption study
Iron absorption was studied in the obese cohort after a 12-h
overnight fast. Serum iron concentrations were measured at
0800 h (baseline) and then 120 min after administration of 1
mg/kg ferrous sulfate (at 1000 h). Change in iron concentration
( iron) was measured by subtracting baseline serum iron from
serum iron at 120 min (30, 31).
Serum hepcidin, IL-6, and leptin evaluation
Before hepcidin analysis, samples were stored frozen at80
C for not more than 8 months. Serum hepcidin-25 (the mature,
active form of the peptide) measurements were performed by a
combination of weak cation exchange chromatography and
time-of-flight mass spectrometry. An internal standard (syn-
thetic hepcidin-24; Peptide International Inc., Louisville, KY)
was used for quantification (32). Peptide spectra were generated
on aMicroflex LT matrix-enhanced laser desorption/ionization
time-of-flight mass spectrometry platform (Bruker Daltonics,
Billerica, MA). Serum hepcidin-25 concentrations are expressed
as nanomoles per liter. The lower limit of detection of this
method was 0.5 nM; average coefficients of variation were 2.7%
(intra-run) and 6.5% (inter-run). The median reference level of
serum hepcidin-25 is 4.2 nM, range 0.5–13.9 nM (33).
IL-6 and leptin were measured by commercially available
ELISA kits. The coefficients of variations within assays were 7%
for IL-6 and 6% for leptin and between assays were 5% for IL-6
and 4% for leptin.
Statistical analysis
Differences between means relative to anthropometric mea-
sures, iron, iron saturation, ferritin,  iron, hepcidin, IL-6, and
leptin of 60obese children and50 controls involved in the second
step of the study were evaluated with the Student’s t test.
A simple regression was used to correlate hepcidin with
BMI-SDS, serum iron, transferrin saturation, and  iron. A
multiple regression analysis, including BMI-SDS, sex, pubertal
stage, and IL-6 values as covariates was used to correlate hep-
cidinwith serum leptin. Variables not normally distributed (hep-
cidin, serum iron, transferrin saturation, and leptin) were log-
transformed before performing the correlations. Data are
expressed as means and SD. We considered statistically signifi-
cant a P value0.05. Stat-Graphics 3.0 Centurion XV software
for Windows was used for all the statistical analyses.
Results
We found lower iron and transferrin saturation (both P
0.05) in obese children compared with lean controls and
higher, althoughnot statistically significant, serumferritin
levels (Table 1). One obese child was anemic. Differences
in hemoglobin levels between obese children and controls
were not statistically significant (Table 1).
Obese children showed higher serum hepcidin com-
pared with controls (P  0.004).
A direct correlation between serum hepcidin and
BMI-SDS (r2 0.33; P 0.0015) (Fig. 1) was observed.
Furthermore, we showed statistically significant inverse
correlations between serumhepcidin and serum iron (r2
0.16; P  0.04), between serum hepcidin and transferrin
saturation (r2 0.22; P 0.005), and among obese chil-
dren, between hepcidin and  iron (r2 0.37; P 0.003)
(Fig. 1).
Finally, we observed higher levels of both IL-6 and
leptin in obese children compared with controls (Table
1) and a direct correlation between hepcidin and leptin
levels (r2  0.27; P  0.006) (Fig. 2). This correlation
remained still significant (P  0.02) when adjusted for
BMI-SDS, sex, pubertal stage, and IL-6 values.
Discussion
Iron is essential for life. It is a trace element that is critical
for optimal physical and cognitive development and per-
formance (3–5). Until recently, few studies had considered
body weight as a factor related to iron deficiency. Interest-
ingly, a recent study, usingdata from theAmericanNational
TABLE 1. General characteristics, iron status indicators,
and hepcidin, leptin, and IL-6 serum levels of 60 obese
children and 50 controls
Obese Controls P
No. of patients
(girls)
60 (29) 50 (25)
Age (yr) 11.3  2.5 10.7  2.7 0.2
Weight (kg) 69.2  17.1 36.5  15.7 0.0001
Height (cm) 148.6  13.6 140.1  25.2 0.03
Prepubertal (%) 50 68 0.3
BMI 30.9  4 17  7.5 0.0001
BMI Z-score 2.7  0.5 0.5  0.7 0.0001
Hemoglobin (g/dl) 12.9  0.8 13.2  1.0 0.08
Iron (g/dl) 68.3  28.8 79  18.6 0.02
Transferrin
saturation (%)
18.6  8,1 22.3  6,6 0.01
Ferritin (ng/ml) 37.8  16 31.4  19 0.06
Hepcidin
(nmoli/liter)
2.8  1.6 1.9  1.6 0.004
IL-6 (pg/ml) 1.7  1.3 1.2  0.7 0.01
Leptin (ng/ml) 34.5  13.8 12.1  12.6 0.0001
Data are expressed as means  SD. Student’s t test has been used to
evaluate differences between means.
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Health and Nutrition Examination Survey III, determined
that overweightAmerican childrenwere twice as likely to be
iron deficient then normal-weight children (8), and similar
findings have since been reported in adults. Considering that
bothobesity and irondeficiency are diseases that continue to
evolve worldwide with significant public health implica-
tions, this association deserves to be explored.
In this study, confirming the linkbetweenadiposity and
serum iron levels, we have observed that obesity is asso-
ciated with poor iron status. Originally, this kind of as-
sociation had been attributed to erroneous dietary habits
of obese patients (7), but recently it has been clarified that
hypoferremia in obesity is not associated with dietary fac-
tors, and an inflammatory-mediated, functional iron de-
ficiency was claimed (12, 14, 15).
Hepcidin is an important regulatorof ironhomeostasis,
producedmainly in the liver. It inhibits iron absorption at
the enterocyte and sequesters iron at the macrophage,
leading in this way to decreased iron status and hypofer-
remia (17–19).Whenerythropoiesis needs tobe increased,
such as during iron deficiency, anemia, and
hypoxia, hepatic production of hepcidin is
rapidly halted and iron is readily absorbed
from the intestine or released from macro-
phages to support the erythron demands
(17). On the other hand, chronic hyper-
stimulation of hepcidin during inflamma-
tory states,mainlymediatedby the cytokine
IL-6, is the leading factor producing the so-
called anemia of inflammation or anemia of
chronic disease, which has features of iron-
restricted erythropoiesis (20, 21).
Because obesity is now considered a
low-grade inflammatory disease, we have
therefore explored the possibility that in-
creased hepcidin levels may represent the
mechanistic link between obesity and iron
homeostasis (14, 34).
Consistent with our hypothesis, we found
inagroupofobesechildrenhigherserumhep-
cidin compared with controls. Furthermore,
we observed inverse correlations between serum hepcidin
and serum iron, transferrin saturation, and among obese
children, between hepcidin and iron absorption.
Intestinal absorption of iron was studied using simply
the iron-loading test based on the increment of iron level
2 h after administrating an iron load (30, 31), and this
constitutes amethodological limitationof the study.How-
ever, the relationbetweenhepcidin concentrationand iron
absorption found in this research is in agreementwith two
recent studies showing that in healthy humans, mature
hepcidin-25 concentration was significantly correlated
with ironabsorption fromfoodand supplemental sources,
evaluated with the use of dual stable-iron-isotope tech-
niques (35, 36), which is considered the gold standard
technique for iron absorption studies.
These data seem to indicate that the hepcidin-inflam-
mation connection may represent the biological frame-
work explaining the association of poor iron status with
obesity.
Nevertheless, the following experimental data reported
in the literature induced us to check a parallel/alternative
framework explaining the increased hepcidin production
in obesity: 1) hepcidin is expressed not only in the liver but
also at both the mRNA and the protein levels in the adi-
pose tissue (22); 2) hepcidin RNA expression is increased
in adipose tissue of obese patients, and there is a positive
correlation between hepcidin expression in the adipocytes
and BMI (22); and 3) leptin, an adipokine secreted by
adipocytes in proportion to their content in triglycerides,
and whose plasma levels are, therefore, particularly ele-
vated in obesity (37, 38), is able, in vitro, to increase hep-
FIG. 1. Correlations in a group of 60 obese children and 50 controls between log-
transformed serum hepcidin and BMI-SDS (r2  0.33; P  0.0015) (A), log-transformed
serum iron (r2  0.16; P  0.04) (B), log-transformed percentage of transferrin
saturation (r2  0.22; P  0.005) (C), and, only in the obese children,  iron (r2  0.37;
P  0.003) (D).
FIG. 2. Correlations in a group of 60 obese children and 50 controls
between serum hepcidin and leptin, both log-transformed (r2  0.27;
P  0.006). The correlation remained significant (P  0.02) when
adjusted for BMI-SDS, sex, pubertal stage, and IL-6 values.
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cidin expression, sharing the same signaling pathway (i.e.
Janus kinase/STAT3) than IL-6 (24). We evaluated serum
leptin concentrations in obese children and the relative
controls and found a strong direct correlation between
leptin andhepcidin levels,which remained statistically sig-
nificant also when data were adjusted for obesity degree,
sex, pubertal stage, and IL-6 values. We speculate that in
the obese patients, leptin could play an important role in
stimulating hepcidin secretion. This idea is strengthened
by a study performed in 1988 (39), before leptin and hep-
cidin discovery (16, 40), showing that genetically obese
ob/ob mice were not iron deficient when fed a diet con-
taining an adequate level of this micronutrient and that
their iron absorption was increased compared with lean
mice (39). Interestingly, after a few years, it has been
shown that this strain of extremely obese mice is homozy-
gous for a mutation of the leptin gene that does not allow
leptin production (40), whereas in obese humans, concen-
trations of leptin are particularly elevated (37, 38). Mea-
suring hepcidin in ob/obmice and in a strain of obesemice
normally producing leptin could help to understand the
specific role of this adipokine in stimulating hepcidin se-
cretion. Furthermore, in the obesity context, consider-
ing that both liver and adipose tissue produce hepcidin,
study of the relative role of these two tissues in stimu-
lating hepcidin secretion may represent an interesting
field of investigation.
In conclusion, we propose that in obese patients, in-
creased hepcidin production, at least partly leptin medi-
ated, can represent the missing link between obesity and
disrupted iron metabolism.
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